^
    CANCER:

    Thyroid Gland Hurthle Cell Carcinoma





    Show legend
    Group by Gene:
    0
    RANK ligand inhibitor
    denosumab
    1
    TrkB receptor inhibitor, TrkC kinase inhibitor, TrkA receptor inhibitor
    larotrectinib
    2
    RET inhibitor
    selpercatinib
    pralsetinib
    3
    PD1 inhibitor
    pembrolizumab
    4
    pan-RAF inhibitor, Multi-tyrosine kinase inhibitor
    sorafenib
    5
    FGFR inhibitor, VEGFR inhibitor, RET inhibitor, c-KIT inhibitor, PDGFR α antagonist
    lenvatinib
    6
    TrkB receptor inhibitor, TrkC kinase inhibitor, ROS1 inhibitor, TrkA receptor inhibitor, ALK inhibitor, JAK2 inhibitor, TNK2 inhibitor
    entrectinib
    No biomarker
    RET fusion
    NTRK3 fusion
    NTRK1 fusion
    NTRK2 fusion
    TMB-H